References
- Child CG III, Turcotte JG. Surgery and portal hypertension. In: Child CG III, editor. The liver and portal hypertension. Philadelphia: Saunders; 1964. p. 50–8.
- Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646–9.
- Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andersen PK, Juhl E, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984;4:430–5.
- Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987;7:660–4.
- Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physician and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997;3:628–37.
- Gines A, Escorsell A, Gines P, Salo J, Jimenez W, Inglada L, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229–36.
- Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002;35:1179–85.
- Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–70.
- Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864–71.
- Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001;7:567–80.
- Dagher L, Moore K. The hepatorenal syndrome. Gut 2001;49: 729–37.
- Cardenas A, Gines P, Bessa X, Salmeron JM, Mas A, Ortega R, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors and shortterm prognosis. Hepatology 2001;34:671–6.
- Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, et al. MELD score is better than Child-Pugh score in predicting 3 month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002;36:494–500.
- Chalasani N, Kahi C, Pinto A, Marathe A, Bini EJ, Pandya P, et al. Model for end-stage liver disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 2002;35:1282–4.
- Forman LM, Lucey MR. Predicting the prognosis ofchronic liver disease: an evolution from Child to MELD: Mayo end-stage liver disease. Hepatology 2001;33:473–5.
- Pagliaro L. MELD: the end of Child-Pugh classification? J Hepatol 2002;36:141–2.
- Brown RS, Jr, Kumar KS, Russo MW, et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002;8:278–84.
- Schlichting P, Christensen E, Andersen PK, et al. Prognostic factors in cirrhosis identified by Cox’s regression model. Hepatology 1983;3:889–95.
- Wiesner R, Edwards E, Freeman R, et al. Model for end stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91–5.